Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for Right Ventricular Dysfunction in Tetralogy of Fallot (Redefine)
NCT02010905Phase 2Unknown
- Sponsor
- University of Amsterdam
- Start
- Dec 2013
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of losartan in tetralogy of Fallot (TOF), Right ventricular dysfunction (RVD), sponsored by University of Amsterdam. Status: unknown.
02
Drugs
losartan
03
Conditions
tetralogy of Fallot (TOF)Right ventricular dysfunction (RVD)
Beyond the preview
Go deeper on NCT02010905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02010905.